EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Organ‐on‐chip for advancing CAR therapy

Lightson Ngashangva, Sunil Martin

Clinical & Translational Immunology · 2025-01 · 14 (2)

DOI: 10.1002/cti2.70024 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical & Translational Immunology, online erschienen am 26.02.2025. Verfasst von Lightson Ngashangva und 1 weiteren Autor:innen. Beteiligte Einrichtung: Biosensors and Biomicrofluidics Laboratory, Transdisciplinary Biology Program Rajiv Gandhi Centre for Biotechnology (RGCB) Thiruvananthapuram Kerala …. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Rajiv Gandhi Centre for Biotechnology, Department of Biotechnology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite great strides of progress, at least 60% of the responding patients relapse to CAR therapy across the blood malignancies. Off‐tumor toxicity apart from functional deficits, cytopenia and infection are the major unfavourable effect of CAR therapy. Models, which faithfully recapitulate the physiology and complexities of immunocompetent tumor microenvironment (TME), paused challenges in capturing potential off‐tumor effects of CAR therapy. Importantly, a landmark change in the legislation allows US Food and Drug Administration and New Drugs and Clinical Trial Rules in India encourages researchers to replace animal testing with cell culture approaches relevant to human system. Organ‐on‐chip (OOC) based on microfluidics technology can potentially emulate multiple biochemical and biophysical intricacies of blood and lymph flow at microscale. Nonetheless, how the evolving microfluidics technology can be enabling to real‐time testing of cell and gene is yet to be realised.

Schlagwörter

Stichwörter der Autor:innen

CAR therapymicrofluidicsorgan‐on‐chiptumor immune microenvironment

Autor:innen und Institutionen

  • Biosensors and Biomicrofluidics Laboratory, Transdisciplinary Biology Program Rajiv Gandhi Centre for Biotechnology (RGCB) Thiruvananthapuram Kerala India.
  • Synthetic Immunology Laboratory, Division of Cancer Research Rajiv Gandhi Centre for Biotechnology (RGCB) Thiruvananthapuram Kerala India.

Förderung

  • Rajiv Gandhi Centre for Biotechnology, Department of Biotechnology, Ministry of Science and Technology, India

Zitieren

APA

Ngashangva, L., & Martin, S. (2025). Organ‐on‐chip for advancing CAR therapy. Clinical & Translational Immunology, 14(2). https://doi.org/10.1002/cti2.70024

Vancouver

Ngashangva L, Martin S. Organ‐on‐chip for advancing CAR therapy. Clinical & Translational Immunology. 2025;14(2). doi:10.1002/cti2.70024

BibTeX
@article{Ngashangva2025,
  author = {Ngashangva, Lightson and Martin, Sunil},
  title = {Organ‐on‐chip for advancing CAR therapy},
  journal = {Clinical & Translational Immunology},
  year = {2025},
  volume = {14},
  number = {2},
  doi = {10.1002/cti2.70024}
}
Kostenlos starten →